Clinical Briefing:
Improving Glycemic Control - Comprehensive Diabetes Management
January/February 2008
The Penn Rodebaugh Diabetes Center at the
Hospital of the University of Pennsylvania is a state-of-the-art
facility dedicated to the treatment and prevention of
diabetes. The Center, unique to the
Philadelphia region, provides comprehensive care exclusively for patients with diabetes, pre-diabetes and
other endocrine problems. As part of a world-class academic medical center, its patients have access to a
multidisciplinary team of diabetes specialists and endocrinologists using advanced
clinical therapies and the latest research.
Case Study
A.B., a 42-year-old male, has a 20-year history of type 1 diabetes complicated
by neuropathy, microalbuminuria, retinopathy and persistent elevated glycosylated
hemoglobin (HbA1c). His insulin regimen included twice daily injections of NPH and
regular insulin. His physician referred him to the Penn Rodebaugh Diabetes Center
for insulin pump therapy evaluation.
On initial assessment, downloaded data from the patient’s home glucose monitor
revealed a one-month blood glucose testing average of 1.4 tests per day. Values
indicated frequent hypoglycemic episodes; his HbA1c was 9.0.
The team determined A.B. needed to achieve improved control before starting
pump therapy. He attended Rodebaugh’s Diabetes Self-Management course. The
counseling session enabled him to more accurately predict his mealtime insulin needs
by using an insulin-to-carbohydrate ratio and an insulin correction factor for elevated
preprandial glucoses. He was switched to basal/bolus therapy, which entails a once
daily basal insulin and rapid-acting insulin with meals.
After 4 weeks, his HbA1c improved marginally to 8.5. He was still not regularly
monitoring his blood glucose, which hampered his ability to determine his insulin needs.
Nevertheless, A.B. was encouraged by his minor improvement. He committed to the
center’s recommendation of four blood glucose checks per day and was placed on
insulin pump therapy. The center’s certified nurse practitioner, who manages the insulin
pump therapy program, helped him select a suitable pump and provided detailed
training on its use.
|

Newer blood glucose monitoring systems make it easier to control
blood glucose levels while mini-19468-16457-Diabetes Clinical:Layout 1 11/7/07
7:15 AM Page 1 mizing hypoglycemia risk. |
|
A.B.’s HbA1c improved to 8.1 six weeks later, but reached a plateau after three
months. Infrequent blood glucose testing was again identified and therefore, continuous
glucose monitoring (CGM) was recommended. CGM traces interstitial glucose sampled
from under the skin of the abdomen and provides real-time glucose levels every five
minutes. The device alarms when hypo- and hyperglycemic events occur. After two
months of CGM, A.B’s HbA1c improved to 6.7 percent with no hypoglycemic events.
He reports “feeling like a new man” and continues follow-up at three-month intervals.
Our Team of Faculty
The Penn Rodebaugh Diabetes Center team includes endocrinologists,
advanced practice nurses, certified diabetes educators, nutritionists and a
podiatrist all in one location. Our approach, as well as our standing as a
predominant research center, enables us to provide patients with the latest
pharmacologic therapy as well as other treatments and technology to deal
with diabetes and its effects.
Medical Director
Mark H. Schutta, MD
Assistant Professor of Medicine
Diabetes
Seth Braunstein, MD, PhD
Associate Professor of Medicine
Carrie Burns, MD
Assistant Professor of Medicine
Serena Cardillo, MD
Assistant Professor of Clinical Medicine
Nayyar Iqbal, MD
Assistant Professor of Medicine
Vanessa Rein, MD
Assistant Professor of Medicine
Michael Rickels, MD
Assistant Professor of Medicine
Kia Morley Mellon, MSN, CRNP
Insulin Pump Program Coordinator
Podiatric Surgery & Medicine
Barry G. Wolff, DPM
Diabetes Education
Kim Olson, RN, MSN, CNS
Frances Love, MSN, APRN, CDE, BC-ADM
Nutrition
Joan Metzner, RD, CDE, LDN
Linda Sartor, RD, MA, CDE, LDN
|

|
Referring Physicians: To speak with a Penn physician
or refer a patient, contact PennHealth through the secure online
referral form or by calling
1-800-789-PENN
(7366). |
 |
 |
 |
|